Guldane Cengiz Seval
Overview
Explore the profile of Guldane Cengiz Seval including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
475
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fotiou D, Badelita S, Katodritou E, Beksac M, Bila J, Spanoudakis E, et al.
Clin Lymphoma Myeloma Leuk
. 2025 Jan;
PMID: 39890518
Background: Multiple myeloma (MM) is predominantly a disease of the elderly, but approximately 10% of patients are younger than 50 years at diagnosis. METHODS: This study aimed to investigate the...
2.
Kastritis E, Beksac M, Badelita S, Katodritou E, Bila J, Spanoudakis E, et al.
Clin Lymphoma Myeloma Leuk
. 2024 Sep;
25(2):e71-e81.
PMID: 39304364
Background: Bortezomib, dexamethasone and cyclophosphamide (VCd) remains a popular regimen, due to its activity and low toxicity, while bortezomib, lenalidomide and dexamethasone (VRd) is widely used in US and Europe;...
3.
Kastritis E, Katodritou E, Badelita S, Bila J, Seval G, Cvetkovic Z, et al.
Leuk Lymphoma
. 2024 Aug;
65(13):2064-2067.
PMID: 39141607
No abstract available.
4.
Isik O, Erol S, Seval G, Gurun Kaya A, Toprak S, Ozdemir Kumbasar O
Exp Clin Transplant
. 2024 Jul;
22(5):373-380.
PMID: 38970280
Objectives: We aimed to reveal the incidence of lateonset noninfectious pulmonary complications and bronchiolitis obliterans syndrome and risk factors involved in development. Materials And Methods: In this cross-sectional study, we...
5.
Lahmer T, Salmanton-Garcia J, Marchesi F, El-Ashwah S, Nucci M, Besson C, et al.
Infection
. 2024 May;
52(3):1191-1194.
PMID: 38771466
No abstract available.
6.
Bay M, Seval G, Coskun O, Gurman G, Erdas N
Cell Biochem Funct
. 2024 May;
42(4):e4035.
PMID: 38715180
Chronic lymphocytic leukemia (CLL) is a chronic lymphoproliferative disorder characterized by monoclonal B cell proliferation. Studies carried out in recent years suggest that extracellular vesicles (EVs) may be a potential...
7.
Salmanton-Garcia J, Marchesi F, Farina F, Weinbergerova B, Itri F, Davila-Valls J, et al.
EClinicalMedicine
. 2024 Mar;
71:102553.
PMID: 38533127
Background: The COVID-19 pandemic heightened risks for individuals with hematological malignancies due to compromised immune systems, leading to more severe outcomes and increased mortality. While interventions like vaccines, targeted antivirals,...
8.
Lahmer T, Salmanton-Garcia J, Marchesi F, El-Ashwah S, Nucci M, Besson C, et al.
Infection
. 2024 Feb;
52(3):1125-1141.
PMID: 38388854
No abstract available.
9.
Musto P, Salmanton-Garcia J, Sgherza N, Bergantim R, Farina F, Glenthoj A, et al.
Hematol Oncol
. 2023 Dec;
42(1):e3240.
PMID: 38050405
Patients affected by multiple myeloma (MM) have an increased risk of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection and subsequent coronavirus (20)19 disease (COVID-19)-related death. The changing epidemiological...
10.
Rossi G, Salmanton-Garcia J, Cattaneo C, Marchesi F, Davila-Valls J, Martin-Perez S, et al.
Int J Infect Dis
. 2023 Oct;
137:98-110.
PMID: 37863310
Objectives: Elderly patients with hematologic malignancies face the highest risk of severe COVID-19 outcomes. The infection's impact on different age groups remains unstudied in detail. Methods: We analyzed elderly patients...